TY  - GEN
AU  - Margulis,Vitaly
AU  - Matin,Surena F
AU  - Tannir,Nizar
AU  - Tamboli,Pheroze
AU  - Swanson,David A
AU  - Jonasch,Eric
AU  - Wood,Christopher G
TI  - Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma
SN  - 1527-3792
PY  - 2008///0811
KW  - Angiogenesis Inhibitors
KW  - therapeutic use
KW  - Antibodies, Monoclonal
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Agents
KW  - Benzenesulfonates
KW  - Bevacizumab
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - Combined Modality Therapy
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Indoles
KW  - Kidney Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Nephrectomy
KW  - methods
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Phenylurea Compounds
KW  - Postoperative Complications
KW  - epidemiology
KW  - Preoperative Care
KW  - Pyridines
KW  - Pyrroles
KW  - Sorafenib
KW  - Sunitinib
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1016/j.juro.2008.03.047
ER  -